BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 21249437)

  • 1. Predictive value of B-type natriuretic peptide levels in patients with paroxysmal and persistent atrial fibrillation undergoing pulmonary vein isolation.
    Degener S; Pattberg SV; Feuersenger H; Bansmann PM; Shin DI; Krummenauer F; Horlitz M
    J Interv Card Electrophysiol; 2011 Apr; 30(3):217-25. PubMed ID: 21249437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma brain natriuretic peptide level after radiofrequency catheter ablation of paroxysmal, persistent, and permanent atrial fibrillation.
    Yamada T; Murakami Y; Okada T; Yoshida N; Toyama J; Yoshida Y; Tsuboi N; Inden Y; Hirai M; Murohara T
    Europace; 2007 Sep; 9(9):770-4. PubMed ID: 17670784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma atrial natriuretic Peptide and brain natriuretic Peptide levels after radiofrequency catheter ablation of atrial fibrillation.
    Yamada T; Murakami Y; Okada T; Okamoto M; Shimizu T; Toyama J; Yoshida Y; Tsuboi N; Ito T; Muto M; Kondo T; Inden Y; Hirai M; Murohara T
    Am J Cardiol; 2006 Jun; 97(12):1741-4. PubMed ID: 16765125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting successful pulmonary vein isolation in patients with atrial fibrillation by brain natriuretic Peptide plasma levels.
    Shin DI; Deneke T; Gorr E; Anders H; Buenz K; Paesler M; Horlitz M
    Indian Pacing Electrophysiol J; 2009 Sep; 9(5):241-6. PubMed ID: 19763191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Addition of B-Type Natriuretic Peptide to Existing Clinical Risk Scores Enhances Identification of Patients at Risk for Atrial Fibrillation Recurrence After Pulmonary Vein Isolation.
    Shaikh AY; Esa N; Martin-Doyle W; Kinno M; Nieto I; Floyd KC; Browning C; Ennis C; Donahue JK; Rosenthal LS; McManus DD
    Crit Pathw Cardiol; 2015 Dec; 14(4):157-65. PubMed ID: 26569657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma brain natriuretic peptide level after hybrid therapy with pulmonary vein isolation and antiarrhythmic drugs for atrial fibrillation.
    Yamada T; Murakami Y; Okada T; Yoshida N; Toyama J; Yoshida Y; Tsuboi N; Inden Y; Hirai M; Murohara T
    Int Heart J; 2008 Mar; 49(2):143-51. PubMed ID: 18475014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary vein reconnection and arrhythmia progression after antral linear catheter ablation of paroxysmal and persistent atrial fibrillation.
    Wasmer K; Dechering DG; Köbe J; Mönnig G; Pott C; Frommeyer G; Lange PS; Kochhäuser S; Eckardt L
    Clin Res Cardiol; 2016 Sep; 105(9):738-43. PubMed ID: 27048420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated brain natriuretic peptide level in patients undergoing atrial fibrillation ablation: is it a predictor of failed ablation or a mere function of atrial rhythm and rate at a point in time?
    Pillarisetti J; Reddy N; Biria M; Ryschon K; Nagarajan D; Murray C; Atkins D; Bommana S; Reddy MY; DiBiase L; Pimentel R; Berenbom L; Dawn B; Natale A; Lakkireddy D
    J Interv Card Electrophysiol; 2014 Aug; 40(2):161-8. PubMed ID: 24800931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryoablation for paroxysmal and persistent AF in patients with structural heart disease and preserved ejection fraction: Clinical outcomes from 1STOP, a multicenter observational project.
    Perego GB; Iacopino S; Molon G; Arena G; Verlato R; Pieragnoli P; Curnis A; Allocca G; Nicolis D; Sciarra L; Catanzariti D; Senatore G; Rovaris G; Brasca F; Tondo C;
    J Cardiol; 2019 Jul; 74(1):19-26. PubMed ID: 30948185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma brain natriuretic peptide concentrations in patients undergoing pulmonary vein isolation.
    Date T; Yamane T; Inada K; Matsuo S; Miyanaga S; Sugimoto K; Shibayama K; Taniguchi I; Mochizuki S
    Heart; 2006 Nov; 92(11):1623-7. PubMed ID: 16740921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stepwise ablation approach versus pulmonary vein isolation in patients with paroxysmal atrial fibrillation: Randomized controlled trial.
    Faustino M; Pizzi C; Agricola T; Xhyheri B; Costa GM; Flacco ME; Capasso L; Cicolini G; Di Girolamo E; Leonzio L; Manzoli L
    Heart Rhythm; 2015 Sep; 12(9):1907-15. PubMed ID: 26051530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline B-type natriuretic peptide: a gender-specific predictor of procedure-outcome in atrial fibrillation patients undergoing catheter ablation.
    Mohanty S; Mohanty P; Di Biase L; Rong B; Burkhardt D; Gallinghouse JG; Horton R; Sanchez JE; Bailey S; Zagrodzky J; Natale A
    J Cardiovasc Electrophysiol; 2011 Aug; 22(8):858-65. PubMed ID: 21371160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in B-Type Natriuretic Peptide Levels and Successful Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure.
    Yanagisawa S; Inden Y; Kato H; Fujii A; Mizutani Y; Ito T; Kamikubo Y; Kanzaki Y; Hirai M; Murohara T
    Pacing Clin Electrophysiol; 2016 Mar; 39(3):225-34. PubMed ID: 26596862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation.
    Fan J; Cao H; Su L; Ling Z; Liu Z; Lan X; Xu Y; Chen W; Yin Y
    J Interv Card Electrophysiol; 2012 Jan; 33(1):93-100. PubMed ID: 21938519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-ablation levels of brain natriuretic peptide are independently associated with the recurrence of atrial fibrillation after radiofrequency catheter ablation in patients with nonvalvular atrial fibrillation.
    Miake J; Kato M; Ogura K; Iitsuka K; Okamura A; Tomomori T; Tsujimoto D; Kato M; Yamamoto K
    Heart Vessels; 2019 Mar; 34(3):517-526. PubMed ID: 30238353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of biatrial defragmentation in patients with paroxysmal atrial fibrillation: results from a randomized prospective study.
    Nührich JM; Steven D; Berner I; Rostock T; Hoffmann B; Servatius H; Sultan A; Lüker J; Treszl A; Wegscheider K; Willems S
    Heart Rhythm; 2014 Sep; 11(9):1536-42. PubMed ID: 24907643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different Effects of Pulmonary Vein Isolation on Quality of Life Between Patients with Persistent and Paroxysmal Atrial Fibrillation.
    Kato M; Miake J; Ogura K; Iitsuka K; Okamura A; Tomomori T; Tsujimoto D; Kato M; Yamamoto K
    Int Heart J; 2019 Nov; 60(6):1328-1333. PubMed ID: 31735784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Remote-controlled magnetic pulmonary vein isolation combined with superior vena cava isolation for paroxysmal atrial fibrillation: a prospective randomized study.
    Da Costa A; Levallois M; Romeyer-Bouchard C; Bisch L; Gate-Martinet A; Isaaz K
    Arch Cardiovasc Dis; 2015 Mar; 108(3):163-71. PubMed ID: 25662699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermediate term outcome after electrogram guided segmental ostial pulmonary vein isolation using an 8 mm tip catheter for paroxysmal atrial fibrillation.
    Pawar P; Vadivelu R; Bachani N; Jeyashree K; Sharma R; Rathi C; Jadwani J; Bera D; Lokhandwala Y
    Indian Heart J; 2019; 71(5):381-386. PubMed ID: 32035520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-center experience of the FIRM technique to ablate paroxysmal and persistent atrial fibrillation.
    Henley P; Foreman JR; Padanilam BJ; Nair GV; Olson JA; Joshi S; Aziz Z; Foster T; Prystowsky EN
    J Cardiovasc Electrophysiol; 2019 Apr; 30(4):493-502. PubMed ID: 30580474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.